Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.36M | 26.46M | 22.16M | 22.14M | 21.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.36M | 26.46M | 22.16M | 22.14M | 21.16M |
| Cost of Revenue | 9.26M | 5.09M | 4.19M | 4.15M | 4.07M |
| Gross Profit | 24.10M | 21.38M | 17.97M | 18.00M | 17.09M |
| SG&A Expenses | 12.24M | 8.68M | 5.77M | 5.71M | 5.43M |
| Depreciation & Amortization | 4.02M | 2.78M | 1.12M | 1.17M | 1.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.52M | 16.58M | 11.12M | 11.17M | 10.86M |
| Operating Income | 7.85M | 9.88M | 11.04M | 10.97M | 10.30M |
| Income Before Tax | 2.96M | 9.49M | 12.29M | 12.94M | 12.68M |
| Income Tax Expenses | -8.59M | -6.37M | -10.32M | -9.74M | -7.70M |
| Earnings from Continuing Operations | 11.55 | 15.86 | 22.60 | 22.68 | 20.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.55M | 15.86M | 22.60M | 22.68M | 20.38M |
| EBIT | 7.85M | 9.88M | 11.04M | 10.97M | 10.30M |
| EBITDA | 11.69M | 12.57M | 12.07M | 12.06M | 11.44M |
| EPS Basic | 0.47 | 0.66 | 0.92 | 0.92 | 0.82 |
| Normalized Basic EPS | 0.15 | 0.29 | 0.32 | 0.33 | 0.32 |
| EPS Diluted | 0.46 | 0.63 | 0.89 | 0.89 | 0.79 |
| Normalized Diluted EPS | 0.14 | 0.29 | 0.32 | 0.33 | 0.32 |
| Average Basic Shares Outstanding | 99.00M | 97.54M | 97.67M | 98.90M | 100.02M |
| Average Diluted Shares Outstanding | 100.38M | 99.44M | 99.44M | 100.60M | 101.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |